Why Most CAPAs Do Not Prevent Recurrence (and How to Fix It)

Ask most sites how their CAPA system is performing and you hear about closure rates and on-time metrics. Ask how many CAPAs actually prevented the issue from returning, and the room goes quiet. Recurrence is the honest measure of a corrective action programme. When the same deviation reappears under a new number, the CAPA did not work, no matter how quickly the last one closed.

When a CAPA root cause stops at the operator

The fastest way to a weak CAPA is a root cause that names a person. "Operator did not follow the procedure" ends the investigation where it should begin. The real questions sit one layer down: was the procedure usable at the point of work, was the training effective or just recorded, and did the system make the correct action the easy action.

Correction is mistaken for corrective action

Cleaning up the spill is a correction. Stopping the spill from happening again is corrective action. Many CAPAs deliver the first, label it the second, and close. The immediate fix feels like progress, so the systemic cause is never addressed.

Effectiveness checks are an afterthought

A CAPA without a defined effectiveness check is a hope, not a control. The check needs a measurable criterion and a real time window. "No recurrence for two quarters across the affected lines" is a check. "Confirmed effective by QA" with no data behind it is not.

The trend is never reviewed across CAPAs

Individually, each CAPA may look reasonable. Viewed together, a cluster of related actions across different deviations often reveals one systemic weakness that no single record named. Without a periodic cross-CAPA review, that pattern stays invisible until an inspector finds it for you.

Building a CAPA system that prevents recurrence

A CAPA system that actually prevents recurrence is built on a few disciplines:

• Push every root cause to the system level before accepting it, and keep asking why until the answer stops naming a person.

• Separate correction from corrective action in writing, so no one confuses the cleanup for the cure.

• Right-size each action so it can be completed, then verify it held with real data.

• Review CAPAs as a set, not one by one, so the pattern behind repeated deviations becomes visible before an inspector points it out.

The metric that actually matters

Closure rate and on-time percentage measure activity, not outcome. The metric that tells you whether the system works is recurrence: how often a closed CAPA is followed by the same deviation under a new number. Track recurrence by area and by root-cause category, and the weak points in the quality system show themselves. Fix those, and the activity metrics take care of themselves.

Frequently asked questions

What is the difference between correction and corrective action in a CAPA?

A correction fixes the immediate problem. Corrective action removes the underlying cause so the problem does not recur. A strong CAPA states both and keeps them distinct.

How do you measure CAPA effectiveness?

Define a measurable criterion and a time window before closing, then verify against real data, for example no recurrence across the affected lines over a defined period.

About the author

Kieran Falvey is Founder and Managing Director of Pharmalliance Consulting Ltd and the creator of Contamination Control by Design (CCbD). He has more than 20 years designing, building and running pharmaceutical facilities worldwide, across FDA, EMA, TGA, PIC/S and Indian FDA (CDSCO) jurisdictions. Global expert in cGMP Compliance, Remediation and Contamination Control, helping Sterile, Non-Sterile, ATMP and Cosmetic companies navigate cGMP compliance issues.

About Pharmalliance Consulting

Pharmalliance Consulting is a GMP compliance consultancy serving pharmaceutical, sterile, non-sterile, OSD, ATMP and cosmetic manufacturers in Ireland, the UK, the EU and the US. It helps sites identify and remediate GMP risks across facilities, quality systems and contamination control, aligned with HPRA, MHRA, EMA and FDA expectations, turning findings into defensible, inspection-ready practice.

Seeing the same findings return? Our GMP Remediation service targets recurrence at the source. Contact Pharmalliance for a CAPA effectiveness review.